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Edited by Felix WielandAbstract We demonstrate that O-linked N-acetylglucosamine
(O-GlcNAc), a ubiquitous protein modiﬁcation in eukaryotes,
suppresses thermal inactivation of Sp1 transcription factor. 6-
Diazo-5-oxonorleucine treatment or O-GlcNAcase overexpres-
sion, which reduced O-GlcNAc levels on Sp1, deteriorated
thermal stability of Sp1 and O-GlcNAc modiﬁed molecules of
Sp1 resist thermal aggregation in vitro. We also showed that
heat-induced elevation of heat shock protein 70 was facilitated
by Sp1 but blunted under low O-GlcNAc levels, suggesting that
O-GlcNAc might upregulate the expression of heat shock pro-
tein 70 through thermoprotection of Sp1, which eventually en-
hanced cellular thermotolerance.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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O-linked N-acetylglucosamine (O-GlcNAc) is a monosac-
charide N-acetylglucosamine modiﬁed by O-linkage on serine
and threonine residues of numerous nucleocytoplasmic pro-
teins, addition and removal of which are executed by O-Glc-
NAc transferase (OGT) and O-GlcNAcase (OGA),
respectively [1]. A number of O-GlcNAc modiﬁed proteins
have been identiﬁed, including RNA polymerase II [2] and
transcription factors, e.g. Sp1, ATF, AP1 [3], and it is now
considered that O-GlcNAc is an important regulatory modiﬁ-
cation [4–6]. Interestingly, heat shock protein 70 (HSP70), one
of major stress-induced chaperons, was recently identiﬁed as
an O-GlcNAc speciﬁc lectin [7]. During research into possible
interrelated mechanisms between O-GlcNAc lectinic and
chaperonic activity of HSP70, we unexpectedly found that
O-GlcNAc modiﬁed molecules of Sp1 resist thermal aggrega-
tion. As well as HSPs and chaperones, several diﬀerent types
of thermoprotecting mechanisms have been reported. A disac-
charide trehalose in yeast provides heat and desiccation toler-
ance [8] and a fucosylation of a protease inhibitor PMP-C
(Pars intercerebralis major peptide C) increases thermal stabil-
ity of the protein molecule [9]. O-GlcNAc is also implicated in
cellular thermotolerance [10,11]. We describe here that O-Glc-
NAc protects Sp1 transcription factor from thermal aggrega-
tion, thereby contributing to eﬃcient heat-induced expression
of HSP70 and thermotolerance of cells.*Corresponding author. Fax: +82 02 923 9923.
E-mail address: hichang@korea.ac.kr (H.I. Chang).
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2.1. Cell culture and transfection
L929 (mouse ﬁbroblast cell), Daoy (human medulloblastoma cell)
and HepG2 (human hepatoma cell) were grown in DMEM with 10%
fetal bovine serum at 37 C under 5% CO2. Transient and stable trans-
fections were carried out using Escort V or Escort V enhanced (Sigma,
St. Louis, MO, USA). Stably transfected L929 cell lines were selected
with 0.75 mg/ml G418.
2.2. Plasmids and cloning
Mouse Sp1 (NCBI accession number AF022363) and O-GlcNAcase
(NCBI accession number AF132214) were obtained by RT-PCR using
primers as follows: Sp1 (forward) 5 0-CGGAATTCATGAGC-
GACCAAGATCACTCCATG-3 0 & (reverse) 5 0-CGGAATTCTTG-
GACCCATGCTACCTTGCATCC-3 0, O-GlcNAcase (forward)
5 0-GGAGGTGCGGCCGCTAATGGTGCAGAAGGAGAGTCAA-
GC-3 0 & (reverse) 5 0-GGAGGTGCGGCCGCACAAGTGTCA-
CAGGCTTCGACCAAG-3 0 (EcoRI and NotI sites for cloning are
underlined). The Sp1 cDNA was cloned into the EcoRI site of
pcDNA3-myc (a gift from Dr J. Ericsson), pGBKT7 (Clontech, Palo
Alto, CA, USA), and pGEX-5X-1 (Amersham Biosciences, Bucking-
hamshire, England). To construct pEGFPC1-GST-Sp1, the GST-Sp1
fragment was produced from pGEX-5X-1-Sp1 by PCR with primers
ﬂanking the region between GST start codon and 3 0 end of the multicl-
oning site of pGEX-5X-1, (forward) 5 0-GTGGTGGTACCATGT-
CCCCTATACTAGGTTATG-3 0 & (reverse) 5 0-GTGGTGGTAC-
CAACGCGCGAGGCAGATCG-3 0 (KpnI site is underlined) and in-
serted into the KpnI site of pEGFPC1 (Clontech). pET14b-Sp1 was
constructed by excising out the Sp1 fragment from pGBKT7-Sp1 with
NdeI and inserting the fragment into the NdeI site of pET14b (Nova-
gen, Madison, WI, USA). O-GlcNAcase was cloned into the NotI site
of pHM6 (Roche, Mannheim, Germany). pcDNA3-myc-Sp4 was con-
structed by inserting a SmaI–XhoI fragment from pBluscript-Sp4 (a gift
fromDr G. Suske) between the EcoRV andXhoI sites of pcDNA3-myc.
To construct pET14b-Sp4, a BamHI–XhoI fragment from pcDNA3-
myc-Sp4 was inserted between the BamHI and XhoI sites of pGADT7
(Clontech) and an NdeI–XhoI fragment from pGADT7-Sp4 was in-
serted between the NdeI and XhoI sites of pET14b.
2.3. Heat aggregation assays and heat treatment of cells
Cells were harvested, resuspended in PBS containing 10% glycerol,
and heated in a water bath at the indicated temperature for 30 min.
Cell extracts were prepared by freeze–thawing three times in buﬀer C
(20 mM HEPES–NaOH, pH 7.9, 420 mM NaCl, 0.2 mM EDTA,
10% glycerol, 0.5 mM PMSF). Total (T), soluble (S), and insoluble
(P) fractions were analyzed by Coomassie blue staining or immuno-
blotting. Heat aggregation assays with puriﬁed recombinant proteins
were performed in 20 mM HEPES–NaOH, pH 7.5, 150 mM NaCl.
To heat-shock cells in situ, 20 mM HEPES–NaOH (pH 7.3) was in-
cluded in growth media and the culture dishes were ﬂoated on a water
bath at the indicated temperatures for 30 min.
2.4. Immunoblotting and immunoprecipitation
Immunoblotting was performed with antibodies against Sp1, HSP70/
HSC70, GST, myc, polyhistidine (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), actin (Sigma) and O-GlcNAc (CTD110.6; Covance,
Princeton, NJ, USA). Signals were visualized using an enhanced chemi-
luminescent reagent (Supersignal West Pico; Pierce, Rockford, IL,
USA). For immunoprecipitation, cell lysates were prepared andblished by Elsevier B.V. All rights reserved.
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protein A/G agarose (Santa Cruz Biotechnology) for another 2 h at
4 C. At the end of incubation, beads were washed with the lysis buﬀer
six times and bound proteins were eluted with Laemmli sample buﬀer.
2.5. Electrophoretic mobility shift assays
Nuclear extracts were prepared as previously described [12]. A Sp1-
binding consensus oligonucleotide (Promega) was end-labeled using T4
polynucleotide kinase and [c-32P] ATP. 20 fmol of labeled oligonucleo-
tide was incubated with 5 lg of nuclear extract and 2 lg of poly (dI-
dC) in a binding buﬀer (20 mMHEPES–NaOH, pH 7.8, 70 mMNaCl,
1 mM MgCl2, 0.5 mM DTT, 5% glycerol) for 30 min at room temper-
ature. For a competition assay, 100-fold molar excessive unlabeled oli-
gonucleotide was included and, for supershift experiments, 200 ng of
anti-Sp1 or anti-Oct1 antibodies were preincubated with nuclear ex-
tracts for 30 min on ice before standard binding assays. At the end
of incubation, the reaction mixtures were electrophoresed on 5% poly-
acryldamide gel in 0.5 · TBE, followed by autoradiography of the
dried gel.
2.6. Recombinant proteins from Escherichia coli
Polyhistidine-tagged proteins were puriﬁed using nickel-chelating
resins. The production of O-GlcNAc modiﬁed proteins was described
previously [13].Fig. 1. Reduction of O-linked N-acetylglucosamine by 6-diazo-5-oxonorleuci
in 5 mM glucose (5G) or 25 mM glucose (25G) with or without 75 lM 6-dia
(O-GlcNAc) levels were revealed by anti-O-GlcNAc immunoblotting. Actin
dishes were transfected with 5 lg of pEGFPC1-GST-Sp1 for 10 h and treated
beads and the levels of O-GlcNAc on GST-Sp1 or of GST-Sp1 polypeptide w
cells were treated as (A) and heat aggregation assays of Sp1 were performed
and the assays were repeated twice. Sp1 Levels were measured by densitomet
(D) Nuclear extracts from L929 cells in (C) were prepared and EMSAs were p
revealed by immunoblotting (lower panel). (E) Daoy cells were treated with or
immunoblotting (middle panel) and heat aggregation assays of Sp1 were perf
together with or without indicated concentrations of glucosamine, for 24 h. T
and anti-actin immunoblotting. (G) HepG2 cells were treated with 0.1 mM D
was immunoprecipitated using anti-Sp1 antibody, followed by anti-Sp1 and
and heat aggregation assays were performed. The assays were repeated tw
expressed as (C). (I) HepG2 cells, which were treated as (H), were heat-sh
expressed as a percent of control (37 C).2.7. Luciferase assays
Luciferase activities were measured using Luciferase assay system
(Promega) and b-galactosidase activities were determined by measur-
ing the amount of yellow color produced after incubation of cell ex-
tracts with ONPG using a spectrophotometer at 420 nm. All assays
were performed in triplicate and the mean ± S.D. was presented.
2.8. Viability assays
Cells on 96 well plates were heat-shocked for the indicated time peri-
ods and viability was measured using XTT method (Welcount; JBI,
Korea) according to the manufacturer’s instructions. All assays were
performed in quintuplicate and the mean ± S.D. was presented.3. Results and discussion
3.1. O-GlcNAc modiﬁcation suppresses thermal aggregation of
Sp1
Cellular levels of O-GlcNAc are altered in response to nutri-
tion [14,15], extracellular signals [16], stress [10,11] and phar-
macological reagents [17–19]. 6-Diazo-5-oxonorleucine
(DON) is known to decrease O-GlcNAc levels by blockingne facilitates thermal aggregation of Sp1. (A) L929 cells were incubated
zo-5-oxonorleucine (DON) for 36 h and O-linked N-acetylglucosamine
levels were monitored as a loading control. (B) L929 cells on 60 mm
as (A) for another 24 h. GST-Sp1 was then puriﬁed using glutathione
ere revealed by immunoblotting with the indicated antibodies. (C) L929
. T, S and P indicate total, soluble and insoluble proteins, respectively,
ry of anti-Sp1 immunoblots and expressed as a percentage of total Sp1.
erformed (upper panel). Sp1 protein levels in the nuclear extracts were
without 75 lMDON for 24 h. The O-GlcNAc levels were examined by
ormed (top panel). (F) HepG2 cells were incubated with 0.1 mM DON,
he whole cell extracts were prepared and subjected to anti-O-GlcNAc
ON alone or with 0.1 mM DON and 3 mM glucosamine for 24 h. Sp1
anti-O-GlcNAc immunoblotting. (H) HepG2 cells were treated as (G)
ice. Sp1 levels in soluble and insoluble fractions were measured and
ocked at 44 C for 30 min and viability was measured. The data was
Fig. 1 (continued)
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mine:fructose-6-phosphate amidotransferase, a key enzyme
converting fructose 6-phosphate into glucosamine 6-phosphate
on the hexosamine biosynthesis pathway (HSP) [17]. We con-
ﬁrmed that O-GlcNAc levels on Sp1 in L929 cells were signif-
icantly reduced by DON, but the elevation of O-GlcNAc on
Sp1 by high concentration of glucose, 25 mM, was not prom-
inent compared with physiological concentration of glucose,
5 mM (Fig. 1A and B). To explore any connection between
O-GlcNAc and thermal inactivation of Sp1, we examined the
patterns of thermal aggregation of Sp1 in L929 cells under
the varied states of O-GlcNAc by determining Sp1 ratio con-Fig. 2. O-GlcNAc inhibits thermal aggregation of Sp1. (A) 2 lg of myc-Sp1 w
haemagglutinin-tagged (HA-) OGA or empty vector (pHM6) for 36 h and
experiments were conducted. Levels of myc-Sp1 and actin in soluble and inso
on 100 mm dishes were cotransfected with 5 lg of myc-Sp1 and 15 lg of
immunoprecipitated using anti-myc antibody and analyzed by immunoblottin
Sp1 or unmodiﬁed His-Sp1 were performed. The assays were repeated twice.
expressed as Fig. 1C. (D) EMSAs were performed with His-Sp1 remaining stained in soluble and insoluble fractions after heat shock at
44 C. As shown in Fig. 1C, most Sp1 molecules in DON-trea-
ted cells were found in the insoluble fraction after heat shock,
whereas a signiﬁcant portion of Sp1 molecules in untreated-
cells remained soluble (left panels). Sp1 aggregation was not
a direct result from the DON treatment because DON alone,
without heat shock, did not induce Sp1 aggregation (Fig. 1C,
right panels). Moreover, Sp1 molecules which remained solu-
ble after heat shock retained their enzymatic activities as exam-
ined by electrophoretic mobility shift assays (EMSAs)
(Fig. 1D). To establish the DON-induced heat-aggregation
of Sp1, we tested whether this phenomenon could be reproduc-as cotransfected into L929 cells on 60 mm dishes together with 6 lg of
heat aggregation assays of myc-Sp1 were performed. Two separate
luble fractions were measured and expressed as Fig. 1C. (B) L929 cells
HA-OGA or empty vector. At 36 h after transfection, myc-Sp1 was
g. (C) Heat aggregation assays with puriﬁed O-GlcNAc modiﬁed His-
Levels of His-Sp1 in soluble and insoluble fractions were measured and
oluble after heat treatment in (C).
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ation of thermal aggregation of Sp1 was also observed in Daoy
(Fig. 1E) and HepG2 cells (Fig. 1F–I). Furthermore, glucosa-
mine, which increases O-GlcNAc by directly entering HSP
[20], suppressed heat aggregation of Sp1 induced by DON in
HepG2 cells (Fig. 1H), accompanying restoration of O-Glc-
NAc levels (Fig. 1F and G), suggesting that the lowered ther-
mal stability of Sp1 by DON was related to the reduction of
O-GlcNAc levels by DON. However, suppression of Sp1
aggregation by glucosamine was not complete, implying that
some other eﬀects by DON might also be involved, although
cell viability at 44 C was unaﬀected by DON (Fig. 1I).
We further conﬁrmed the relationship between O-GlcNAc
and Sp1 thermal stability in two other ways. To achieve an
enzymatic reduction of O-GlcNAc on Sp1 in cells, myc-tagged
Sp1 (myc-Sp1) was cotransfected into L929 cells with hemag-
glutinin-tagged OGA (HA-OGA) and thermal aggregation of
myc-Sp1 was analyzed. As shown in Fig. 2A and B, thermal
aggregation of myc-Sp1 was increased by OGA coexpression,
which decreased O-GlcNAc on myc-Sp1, whereas the solubil-
ity of actin was not changed. Furthermore, O-GlcNAc modi-
ﬁed polyhistidine tagged-Sp1 (His-Sp1), which was produced
in E. coli as previously described [13], resist thermal aggrega-
tion, whereas unmodiﬁed His-Sp1 was almost completely
insolubilized by heat (Fig. 2C). Sp1 molecules which remained
soluble after heat treatment still retained their DNA binding
activities as identiﬁed by EMSAs (Fig. 2D). Sp4 is a Sp1-
homolog transcription factor having similar structural features
to Sp1 [21] and we found that O-GlcNAc also suppressed ther-
mal aggregation of Sp4 (Fig. 3A–C). Therefore, we conclude
that O-GlcNAc suppresses thermal aggregation of Sp1.Fig. 3. O-GlcNAc inhibits thermal aggregation of Sp4. (A) Heat aggregatio
performed as Fig. 2C. (B) L929 cells were transfected with myc-Sp4 for 8 h an
heat aggregation assays. The assays were repeated twice. Levels of myc-
immunoprecipitated using anti-myc antibody from L929 cells in (B) and ana3.2. Sp1 and O-GlcNAc are essential for eﬃcient heat-induced
expression of HSP70
The expression of heat shock proteins (HSPs) is known to be
directed by heat shock transcription factors [22], but other
basal transcription factors including Sp1 also aﬀect constitu-
tive and heat-induced expression of HSP70 [23,24]. Consistent
to these previous reports, we found that Sp1 could activate
HSP70 expression. When L929 cells were cotransfected with
myc-Sp1 and pHSP70B-Luc (a HSP70B promoter-harboring
luciferase reporter construct), the expression of the reporter
construct was facilitated by Sp1 overexpression in both
heat-induced and uninduced conditions (Fig. 4A and B).
Heat-induced expression of endogenous HSP70 genes was also
increased by Sp1 overexpression (Fig. 4C).
Thus, we addressed if heat-induced expression of HSP70
would be aﬀected by O-GlcNAc, which controlled heat resis-
tance of Sp1 as we elucidated above. As shown in Fig. 4D,
post-heat expression of pHSP70B-Luc was repressed by
DON and OGA coexpression in L929 cells. The heat-induced
expression of endogenous HSP70 was also signiﬁcantly inhib-
ited by DON treatment and in OGA-stably transfected L929
cells (L929-OGA, Fig. 4E) compared with control cells
(Fig. 4F). These results indicate that O-GlcNAc is essential
for eﬃcient post-heat expression of HSP70. Sp1 was known
to be vulnerable to proteasomal degradation in low levels of
O-GlcNAc, but the total amounts of Sp1 in L929 cells seemed
to be almost unaﬀected by either DON treatment or OGA
overexpression in our assays (lower panels in Fig. 4F). The
observation of the reduction of HSP70 expression under low
O-GlcNAc levels prompted us to investigate the eﬀect of
O-GlcNAc on thermotolerance. As shown in Fig. 4G,n assays of puriﬁed O-GlcNAc modiﬁed or unmodiﬁed His-Sp4 were
d incubated with or without 75 lMDON further for 24 h, followed by
Sp4 were measured and expressed as in Fig. 1C. (C) myc-Sp4 was
lyzed by immunoblotting.
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Fig. 4. Sp1 andO-GlcNAc are essential for eﬃcient heat-induced expression ofHSP70. (A) L929 cells on 12wells were cotransfectedwith pHSP70B-Luc,
pCMV-b-galactosidase, and increasing amounts of myc-Sp1. 36 h later, luciferase and b-galactosidase activities weremeasured. (B) L929 cells on 12 wells
were cotransfected with pHSP70B-Luc and myc-Sp1 or empty vector for 36 h and then heat-treated. The cells were incubated further for the indicated
periods at 37 C and luciferase activities weremeasured. (C) L929 cells on 6 wells were transfected with 6 lg ofmyc-Sp1 or empty vector for 36 h and then
heat-treated. After recovery for the indicated periods, immunoblotting was performed with the indicated antibodies. (D) L929 cells were incubated with
or without 40 lMDON for 24 h and transfected with 1 lg of pHSP70B-Luc for 5 h (left panel). 0.2 lg of pHSP70B-Luc was cotransfected together with
2 lg of HA-OGA or empty vector for 18 h (right panel). At the end of transfection, cells were heat-treated, recovered for indicated periods and luciferase
activities weremeasured. (E) L929 cells were stably transfected with pHM6 (Control) or pHM6-OGA (L929-OGA). The expression of HA-OGA (middle
panel) and O-GlcNAc levels (upper panel) were examined by immunoblotting. (F) L929 cells, which were preincubated with or without 40 lMDON for
30 h (left panels), or stable cell lines, control and L929-OGA (right panels), were heat-treated at 44 C and recovered for the indicated periods. Cells were
lysed directly in Laemmli sample buﬀer and immunoblotted using the indicated antibodies. (G) L929 cells, which were preincubated with or without
40 lMDON (left panel), or control/L929-OGA cell lines (right panel) were heat-treated at 44 C on 96 well plates and return to 37 C. 6 h later, cells were
heat-shocked again at 48 C for the indicated time and viability was measured. The data were expressed as a percent of control (37 C instead of 48 C).
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(48 C) challenged at 6 h after previous mild heat shock
(44 C), so-called acquired thermotolerance, was signiﬁcantly
reduced by DON treatment or OGA overexpression. Consid-
ering that Sp1 thermal inactivation was suppressed by O-Glc-
NAc and that both Sp1 and O-GlcNAc were required for
eﬃcient heat-induced expression of HSP70, O-GlcNAc may
aﬀect HSP70 expression, at least partly, by controlling Sp1
thermal stability, thereby enhancing thermotolerance of cells.
Although we showed that O-GlcNAc was able to inhibit
thermal aggregation of Sp1, the mechanism is not clear. One
hypothesis is that hydrophilic O-GlcNAc residues on polypep-
tides may hinder thermally exposed hydrophobic regions from
sticking together, letting them refolded either spontaneously
unless severely denatured or by chaperones. This hypothesis
seems interesting because it is reminiscent of typical chaper-
ones, which also block protein aggregation by shielding the
interactive hydrophobic regions of unstructured polypeptides
[25,26].
In the middle of our research, two groups reported similar
ﬁndings that O-GlcNAc was globally increased immediately
upon heat exposure and the increased O-GlcNAc levels were
correlated with thermotolerance of cells [10,11]. Sohn et al.
[11] also suggested that global protein aggregation by heat
might be suppressed by OGT and Zachara et al. [10] showed
that the increase of O-GlcNAc levels accompanied enhanced
heat-induced expression of HSP70 and HSP40. Now, our re-
sults give a clue to a question ‘‘how’’ by showing thermopro-
tection of a speciﬁc protein by O-GlcNAc. In the other
hand, Williams and Morimoto [24] reported that maximal
expression of HSP70 required basal promoter elements includ-
ing ATF, AP1, GC box, CCAAT, indicating that basal tran-
scription factors were required for HSP70 expression in
addition to heat shock factors, which is consistent to our re-
sults of promotion of HSP70 expression by Sp1. Interestingly,
ATF and AP1 are also O-GlcNAcylated [3], so it will be nec-
essary to test if thermal stability of these factors is also aﬀected
by O-GlcNAc like Sp1.
In this context, our results might provide a preliminary but
possible mechanism linking between O-GlcNAcylation and
thermotolerance. Combined with the previous reports [10,11],
O-GlcNAc seems to function as a guard mechanism against
heat stress primarily at the onset of heat stress before signiﬁ-
cant accumulation of HSPs by protecting proteins from ther-
mal damage and also essential for the full activation of heat
shock responses by ensuring eﬃcient heat-induced expression
of HSP70.
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